Breast Cancer
October 2016 Vol 7, No 9 | September 23, 2016
Metastatic breast cancer (MBC) patients receive an overwhelming amount of information at the time of diagnosis, with most of the information transferred through oral conversations and abstract medical terminology that’s difficult for patients to understand.
October 2016 Vol 7, No 9 | September 23, 2016
The study was conducted by the nurse navigator at Sarah Cannon Cancer Institute at Research Medical Center in Kansas City, a member of the oncology service-line for HCA. Nurse navigators are exposed to many processes in the cancer care system and recognize when systems are not at optimal functioning.
Allyson H. Daugherty, PT, CLT, CFM, Judy Koutlas, RN, MS, OCN, Debra C. Mascarenhas, RN, BSN, BSBA, CBCN
October 2016 Vol 7, No 9 | September 23, 2016
Approximately 42% of breast cancer survivors develop clinically detectable lymphedema within 5 years of treatment. Early intervention and education is crucial to decrease long-term morbidity and improve patient outcomes.
October 2016 Vol 7, No 9 | September 23, 2016
Implementation of the imaging nurse navigator role has helped remove barriers for breast care delivery surrounding access, timeliness, volumes, and outmigration.
October 2016 Vol 7, No 9 | September 23, 2016
Through a grant provided by the American Cancer Society, AltaMed Health Services (AltaMed) implemented a Breast Cancer Outreach and Screening Program with multiple elements. The overall program aims to provide breast health education and screening mammograms to eligible women who are patients at the West Covina, El Monte, and Santa Ana-Bristol clinics.
October 2016 Vol 7, No 9 | September 23, 2016
In a recent discussion review on the number of women being screened at the Women’s Imaging Center, the nurse navigator noticed that there was no screening program for women in the inpatient setting.
October 2016 Vol 7, No 9 | September 23, 2016
This project highlights the importance of nurse navigators and interdisciplinary collaboration and demonstrates how they positively affect healthcare and patient outcomes.
Annette Leon, PhD, MS, FACMG, Lauren Ryan, MS, LCGC, Lilian Servais, MS, LCGC, Jeroen van den Akker, PhD
October 2016 Vol 7, No 9 | September 23, 2016
We reviewed the personal and family histories of patients found to have multiple pathogenic or likely pathogenic mutations when tested clinically for 19 genes for hereditary breast and ovarian cancer and the implications for the patient and his or her family.
October 2016 Vol 7, No 9 | September 23, 2016
Stomatitis is a common adverse event (AE) of mTOR inhibition. Nurses are critical in educating patients about and treatment of AEs.
Susan E. Appling, Kathy J. Helzlsouer, Dawn Henninger, Ryan MacDonald, Shannon Manocheh, Susan Scarvalone, Arti P. Varanasi
August 2016 Vol 7, No 7 | August 3, 2016
The authors present findings from their study on the potential of centralized virtual navigation for low-income populations to improve treatment completion.
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512